Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function - Lev, Eli I; Osende, Julio I; Richard, Merwin F; Robbins, Jonathan A; Delfin, Jenny A; Rodriguez, Oswaldo; Sharma, Samin K; Jayasundera, Tim; Badimon, Juan J; Marmur, Jonathan D (Journal of the American College of Cardiology, 2001)
Keywords: Abciximab; Antibodies, Monoclonal - pharmacology; Biological and medical sciences; Blood Platelets - drug effects; Blood Platelets - physiology; Blood. Blood coagulation. Reticuloendothelial system; Drug Therapy, Combination; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments - pharmacology; Male; Medical sciences; Middle Aged; Peptides - pharmacology; Pharmacology. Drug treatments; Platelet Aggregation - drug effects; Platelet Glycoprotein GPIIb-IIIa Complex - pharmacology; Tirofiban; Tyrosine - analogs & derivatives; Tyrosine - pharmacology; ACS; CPA; NS; PPACK; PCI; GP; TRAP; MI; PRP; Human; Glycoprotein IIbIIIa; Abciximab; Toxicity; Treatment efficiency; Coronary artery; Coagulation; Instrumentation therapy; Exploration; Antiplatelet agent; Eptifibatide; Chemotherapy; Treatment; Tirofiban; Platelet function; Combined treatment; Antagonist; Biological receptor